Tobacco has been sucked, chewed and smoked for many centuries in different civilisations [1] [2] [3] [4] . Tobacco smoking spread from North America to Europe around the middle of the sixteenth century and thereafter became an increasingly widespread habit around the world. When first introduced to Europe, smoking was recommended for medicinal purposes but the effects of the habit soon became the focus of some suspicion and scrutiny. One of the notable opponents of tobacco as being a noxious vice was King James, who as James VI of Scotland had become King James I of the United Kingdom and who published in 1604 A Counterblaste to Tobacco.
Initially tobacco smoking revolved around use of pipes. Cigars were introduced to Spain around 1600 and the first cigars were manufactured in Sweden in 1814 [5] . During the eighteenth century the cigarette, initially recognised as a symbol of lower-class behaviour, became a widely accepted form of tobacco smoking and cigarette-manufacture was established in Havana (in 1853) and in London (in 1856) and shortly afterwards in north America [2] .
Tobacco smoking in the form in which we know it today, is a relatively recent phenomenon: more recent than the automobile, the aeroplane or the telephone [6] . The development of the manufactured cigarette in the late nineteenth century was a major influence in establishing the modern tobacco-smoking situation. The convenience of cigarettes was demonstrated on a large-scale during the First World War (1914) (1915) (1916) (1917) (1918) when 60% of tobacco donated to the Allies on the Western Front was in the form of cigarettes [7] . This popularised cigarette smoking among men although their virtual monopoly on this form of tobacco smoking was gradually eroded by women during the 1920s and 1930s.
Following the Second World War (1939) (1940) (1941) (1942) (1943) (1944) (1945) , approximately three-men-in-four smoked cigarettes and somewhat less than one-woman-in-four had acquired the habit Cigarette smoking was on the way to becoming a ubiquitous habit. Cigarettes were relatively inexpensive and widely available and every group of society indulged in the habit. Cigarette advertising was virtually unrestricted, even appearing in medical journals [8] , and different brands, and the smoking habit, were endorsed by movie stars, sporting heroes and even by doctors. The only cloud on the horizon was the adverse effects being increasingly demonstrated to be associated with the cigarette smoking habit.
Adverse effects associated with tobacco smoking
Clemmesen [1] provides and extensive, scholarly review of the emergence of the link between tobacco smoking and chronic disease, particularly cancer, which has been developing for centuries. Clemmesen attributes to Samuel Thomas Sommering (1795) the first comment on tobacco smoking as a cause of cancer. In his treatise for a prize offered by the Rhineland-Frankfurt Society, Sommering wrote: 'Thus, carcinoma of the lip is most frequent where people indulge in (the use of) tobacco pipes. For the lower lip is particularly attacked by carcinoma, because it is compressed between the pipe and the teeth' [9] .
The global cancer burden
Estimates of the global cancer burden have been made for 1975 [10] , 1980 [11] and 1985 [12] : these estimates are for all forms of cancer excluding non-melanoma skin cancers. In men there were an estimated 3,849,000 incident cases in 1985. The commonest form of cancer is lung cancer with an estimated 667,000 incident cases in 1985. The estimated numbers of cases of lung cancer has increased by 44% over the 10-year period covered by these estimates. Other forms of cancer which have increased notably are colorectal cancer, prostate cancer, bladder cancer and lymphoma. While some of these increases could be due to better precision in the estimation methodology, there is also likely to be a real component to these increases.
In women, it was estimated that there were 3,774,200 incident cases of cancer in 1985. Breast cancer is the commonest form of cancer estimated in 1985 as producing 719,000 new cases. This is a large increase over the estimated 541,200 incident cases in 1975: an increase of 33% in ten years. A similar increase has taken place in cancer of the oral cavity, colorectum and lymphoma. The largest relative increase of cancer in women has been in lung cancer which increased from 126,700 in 1975 to 219,000 in 1985, an increase of 73%. This can almost entirely be explained by changes in smoking patterns in women in many parts of the world [13] .
The estimated numbers of new cases of cancer worldwide increased from 5.9 million in 1975, through 6.4 million in 1980 to attain 7.6 million in 1985. Assuming that the age-specific incidence rates remain constant at the 1985 levels, it was estimated that there would be 8.4 million new cases in 1990 and 10.3 million new cases in the year 2000 [12] . It could be deduced that it seems likely that the number of new cases of cancer world-wide has doubled between 1970 and 2000. Beyond 2000, the absolute numbers of cases of cancer will likely increase as the postWorld War II 'Baby Boom' reach ages where the agespecific rates of cancer start to increase. In many countries this generation is the first not to have suffered a great war to reduce their numbers and to have benefited from the advances in medical care and treatment witnessed in the second half of this century. Most of them are still alive at age 50 compared to the same situation in many countries for the preceding generations.
Cigarette smoking and cancer: The modern plague
It is estimated that between 25% and 30% of all cancers in developed countries are tobacco-related. From the results of studies conducted in Europe, Japan and North America, between 83% and 92% of lung cancers in men, and between 57% and 80% of lung cancers in women, are attributable to cigarette smoking. Between 80% and 90% of cancers arising in the oesophagus, larynx and oral cavity are related to the effect of tobacco, both acting singly and jointly with alcohol consumption. Cancers of the bladder, pancreas, stomach, kidney and cervix are causally related to tobacco smoking and there have been suggestions of an association with cigarette smoking and an increased risk of leukaemia and colorectal cancer although the causal nature of these latter associations has not been accepted. Because of the length of the latency period, tobacco-related cancers observed today are related to cigarette smoking patterns over two decades ago. Consequently, foUowing any decrease in smoking prevalence there will be a period of time which will elapse before any decrease in the incidence of tobaccorelated cancers is apparent: there will be a more rapidly evident decline in cardiovascular disease.
There is now strong evidence of the adverse health consequences of Environmental Tobacco Smoking (ETS) sometimes referred to as passive smoking. On the basis of the available epidemiological data, the United States Environmental Protection Agency declared in 1992 that ETS was a proven lung carcinogen in humans. The risk of lung cancer is increased in non-smoking women who have husbands who smoke tobacco and there are associations with a number of other conditions, including the risk of asthma in children, associated with parental smoking [14] . There also appears to be an increased risk of myocardial infarction due to exposure to ETS and the adverse health consequences in children whose parents smoke includes an increase in the frequency and severity of asthma.
Tobacco can kill in two dozen ways including causes such as lung cancer and other forms of cancer, heart disease, strokes and chronic bronchitis and other respiratory diseases. Smokers have three times the death rate in middle-age (between the ages of 35 and 69) than nonsmokers and about half of regular cigarette smokers will eventually be killed by their habit. Many of these are not particularly heavy smokers but they can be characterised by having started smoking while a teenager. Half of the deaths from tobacco will take place in middle age (35-64) and each will lose approximately 20-25 years of nonsmokers life expectancy: the remaining half of the deaths will take place after the age of 70. However, there is clear and consistent evidence that stopping smoking before having cancer or some other serious disease avoids most of the later excess risk of death from tobacco even if smoking stops in middle age.
World-wide, smoking kills three million people each year: the second half of the Twentieth century was notable for 60 million deaths caused by tobacco world-wide. In most countries the worst consequences of the Tobacco Epidemic are yet to come, particularly among women in developed countries and in populations of developing countries, since by the time the young smokers of today reach middle or old age there will be about ten million deaths each year from tobacco. Approximately 500 million of the world's population today can expect to be killed by tobacco, 250 million of these deaths being premature and occurring in middle age [15, 16] .
The situation in Europe is particularly worrying. The European Union is the second largest producer of cigarettes (694 billion in 1993) after China (1,675 billion) and the major exporter of cigarettes (218 billion). In Central and Eastern Europe there is a continual increase in the smoking habit. Of the six World Health Organisation (WHO) regions, Europe has the highest per capita consumption levels of manufactured cigarettes and faces an immediate and major challenge in meeting the WHO target for a minimum of 80% of the population to be non-smoking. Currently (Spring 1994) in the European Union, 42% of men and 28% of women smoke. The smoking prevalence in women is artificially reduced by the low rates reported in southern Europe where there is evidence that these rates are rising and seem set to continue to rise over the next decade. In addition, smoking prevalence in the age range 25-39 years is high (55% in men and 40% in women) and can be expected to have a profound influence on the future cancer pattern. It is especially worrying that the smoking prevalence among General Practitioners and other health professionals, who play an exemplary role in health behaviour, remains high in many parts of Europe. This should be a target for immediate action.
It has been demonstrated that changes in cigarette consumption are affected mainly at a societal level rather than by actions, such as individual smoking cessation programmes, targeted at individuals. Actions such as advertising bans and increases in the price of cigarettes have been shown to influence cigarette sales, particularly among adolescents. Therefore, a Tobacco Policy is necessary to reduce the health consequences of tobacco, and experience shows that this should be targeted via a variety of actions aimed at stopping young people starting smoking and helping smokers to quit. To be efficient and successful, a tobacco policy has to be comprehensive and maintained over a long time period. Increased taxes on tobacco, total bans on direct and indirect advertising, smoke-free enclosed public areas, education, effective health warning labels on tobacco products, a policy of low maximum tar and nicotine levels in cigarettes, encouragement of stopping smoking and individual health interventions have to be implemented urgently.
The importance of adequate interventions is demonstrated by the relatively low lung cancer rates in Scandinavian countries which, since the early 1970s, have adopted integrated central and local policies and programmes against smoking. In the United Kingdom, tobacco consumption has declined by 30% since 1970 and lung cancer mortality among men has been decreasing since 1980 although the rate remains high. In France, between 1992 and 1994 there has been an 8% reduction in tobacco consumption due to the implementation of antitobacco measures introduced by the Loi Evin.
Tobacco control remains more than ever an important Public Health priority. There are various elements to any Tobacco Control Policy but the importance of the medical and oncological community in setting an example is paramount. A particularly fundamental exemplary role is that of the general practitioner who is so often the interface between the individual and the health services. Health maintenance and disease prevention are increasingly important aspects of the work of the general practitioner and the single most important of these is advice about the health hazards of tobacco smoking.
Tobacco recommendations
Tobacco smoking poses a unique Public Health problem in that if it were discovered today it would automatically be banned: the importance of the role of tobacco in cancer causation and prevention was recognised by it being considered as the first point of the European Code Against Cancer [17] . Its ubiquitous usage is an accident of history which cannot be reversed by an unenforceable ban on its use. Initiation into smoking depends mainly on social pressures, while maintenance of the habit depends to a considerable extent on nicotine addiction. Tobacco is manufactured and marketed by an international industry which is overtly committed to market expansion. For several decades, international medical opinion has favoured market shrinkage by every means available in order to limit the long-term adverse health effects surrounding the use of this product. Government action has been remarkably variable on Tobacco Control in marked contrast to the relatively consistent responses to such issues as immunisation. Vigorous Public Health action has reaped rewards in the form of reducing mortality from tobacco-related diseases in some countries, thereby demonstrating that the problem of tobacco use, while slow to respond to control initiatives, can be progressively controlled.
Under these circumstances, it is not possible to meekly accept the status quo. The High-Level, Cancer Experts Committee of the 'Europe Against Cancer' Programme of the European Commission, has considered the evidence demonstrating tobacco as a cause of premature death from cancer and other serious diseases among citizens of the European Union, together with assessments of the magnitude of the tobacco problem in Europe and elsewhere, to present an alarming situation and a continuing serious hazard to Public Health. The recommendations outlined below, presented in no order of priority reflect this view.
• The High-level, Cancer Experts Committee of the 'Europe Against Cancer' Programme (hereafter referred to as the Cancer Experts Committee), taking into account the advice of the Helsinki Tobacco Consensus Conference, recommends to the European Union that measures to reduce Tobacco Consumption be the top health priority for the European Commission and European Parliament for the quinquennium 1997-2001. Historically, the composition of the cigarette, unlike any other marketed poison, has been basically unregulated. In recent years some limits have been recommended or mandated for tar and nicotine contents of cigarettes. Manufacturers are nevertheless allowed to introduce additives without demonstrating their freedom from toxicity either before or after combustion. Government Departments have avoided taking responsibility for authorising the inclusion of substances to a mixture which changes upon combustion and is carcinogenic. They have had no qualms about controlling manufacturers of diverse agents including antibiotics and soft drinks by formal regulation.
• Therefore, the Cancer Expert Committee recommends that cigarette content should be the subject of government regulation throughout the European Union. From 31st December 1997 onwards: i) Only tobacco, tobacco paper, filter materials and tobacco extracts should be permitted in cigarettes sold and manufactured in the European Union. Any additives to be included should be demonstrated free of toxicity and any other harmful effects on health, in burnt and unburnt form. Additives to cigarettes should be monitored and included on the labelling as with other drugs and foodstuffs on the market. The tar content of cigarettes should be limited to a maximum of 12 mg as currently mandated for 31st December 1997. The nicotine content of cigarettes should be limited to 1 mg from 31st December 1997. ii) The maximum allowable limits of the tar (12 mg) and nicotine (1 mg) contents of cigarettes sold or manufactured in the European Union should be decreased by 10% per annum until levels of 5 mg tar and 0.5 mg nicotine are met. iii) By 31st December 1997, labelling requirements similar to those currently applicable in Australia should be in force. In particular, the health warning should be strengthened, made more prominent and the labelling should include a toll-free, telephone number from which accurate information about smoking, its health consequences and its avoidance can be obtained. By 31st December 2000, generic packaging of cigarettes must be introduced. Further research should be commissioned at present to further lower these minimum levels of tar (5 mg) and nicotine (0.5 mg).
• The Cancer Experts Committee notes that smoking begins in adolescence and that reduced availability is an anti-smoking influence. On this basis it is recommended that steps should be taken aiming to reduce the availability of tobacco products to children and adolescents. Self service displays and vending machine sales should be withdrawn.
• The Cancer Experts Committee considers that there is no rationale for the promotion of a known carcinogen by any means, direct or indirect. It therefore recommends in the strongest possible terms that the measures, relevant to this issue, already proposed by the Commission and agreed to by the European Parliament be implemented without delay. There is widespread agreement among health education authorities that tobacco advertising, both direct and indirect, plays a role in encouraging the uptake of smoking and should be severely curtailed. • In the light of evidence that price increases are a deterrent to smoking, have a greater effect on children and, further, that regular price increases are necessary to maintain the effect, the Cancer Expert Committee recommends that the European Commission pursues a tax policy aimed at the upward harmonisation of the retail price of tobacco products. Regardless of the right of the smoker to smoke, non smokers have the right to breathe air that is as unpolluted as possible. Pollutants such as asbestos and benzene are limited by law to the lowest practical level attainable. The lowest level attainable of tobacco smoke is zero. While cancer risk is not perhaps as immediate as that of triggered asthma attacks, orthodox Public Health practice requires that non smokers be protected from tobacco smoke in the workplace and public places in the broadest sense. The common-sense of this recommendation is emphasised by various legal precedents which show that employers in some countries are vulnerable at law for breach of the elementary requirement to provide a safe workplace.
• To protect the rights of non-smokers and prevent involuntary exposure to environmental tobacco smoke, the Cancer Experts Committee recommends that smoking be banned in public places and in the workplace. Separate smoking sections may be introduced in the workplace, and in places such as restaurants and bars. Smoking should be prohibited on air flights within the European Union. The Cancer Expert Committee considers there is a clear and obvious need for comprehensive education programs to inform professionals, the public and children of the dangers of smoking, as well as to explain the rationale for the anti smoking measures recommended here. Education programs obviously need to be culture and language specific.
With this in mind the Cancer Experts Committee recommend the following general proposals, aware that some have already been adopted and implemented by the European Commission in the context of the on-going 'Europe Against Cancer' Programme.
• That each country be encouraged to form a coalition of groups involved in public health and education to be charged with organising appropriate national programmes whose principal aim is to initiate action to reduce tobacco consumption and its serious effects.
• That national groups be encouraged to join in a Europe wide collaborative network aimed at sharing information and expertise.
• That the European Commission sponsor regular, at least annual, meetings of this collaborative network.
• That relevant public health/education/behavioural research be a function of the national and European groups.
• That surveillance and monitoring of education programmes, behavioural trends, smoking prevalence, knowledge and relevant attitudes be a priority and be funded as part of the comprehensive program.
• That programmes directed specifically at health professionals be developed in those countries where smoking prevalence is high in these groups.
• That there be a designated centre whose objectives should include coordination of national surveillance programmes, the continual evaluation of the scientific literature of the association between tobacco usage and disease and the patterns of tobaccorelated disease within the European Union. This Centre should be mandated to prepare an Annual Report for submission to the European Parliament and Council.
• The Cancer Expert Committee strongly supports the action to end duty free sales of cigarettes and tobacco products within the European Union. In conclusion, a Meeting Report in the pages of this Journal in 1995 reported that the extent of smoking as a risk factor for cancer as well as other diseases was still emerging [18] . This meeting of an expert group on cancer epidemiology, working subsequently within the framework of the Europe Against Cancer Experts Committee decision to have a Consensus Conference on Tobacco, formed the basis of the Recommendations agreed by European Cancer Experts on 2 October 1996 at the Helsinki Tobacco Consensus Conference. These recommendations represent a series of achievable actions whose implementation could lead to major reductions in tobacco smoking in Europe, provide leadership for other regions of the world in the field of Tobacco Control, and lead to significant reductions in cancer incidence and mortality within all the countries of Europe. The oncological community has a major role to play in the successful implementation of this package of tobacco control measures. Oncologists, singly and collectively, have the responsibility for supporting Cancer Control through Tobacco Control: their successful interaction with politicians and the general public throughout Europe could contribute to the prevention of a large number of deaths.
